Adiponectin self-regulates its expression and multimerization in adipose tissue: An autocrine/paracrine mechanism?

Medical Hypotheses

Volumn 78, Issue 1, 2012, Pages 75-78

  Lin, Huan ^a   Li, Zhen ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; OLIGOMER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; AUTOCRINE EFFECT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION REGULATION; IMMUNOASSAY; INSULIN RESISTANCE; METABOLIC DISORDER; MOLECULAR WEIGHT; PARACRINE SIGNALING; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION;

ADIPONECTIN; ADIPOSE TISSUE; AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; AUTOCRINE COMMUNICATION; BERBERINE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HOMEOSTASIS; HUMANS; IMMUNOASSAY; INSULIN RESISTANCE; METABOLIC DISEASES; MODELS, BIOLOGICAL; PARACRINE COMMUNICATION; PROTEIN MULTIMERIZATION; RIBONUCLEOTIDES;

EID: 83155180347     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.07.063     Document Type: Article

References (46)

1. Scherer P.E., Williams S., Fogliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270:26746-26749.
2. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., Matsubara K. CDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (dioseost abundant gene transcript 1). Biochem Biophys Res Commun 1996, 221:286-289.
3. Matsuda M., Shimomura I., Sata M., Arita Y., Nishida M., Maeda N., et al. Role of adiponectin in preventing vascular stenosis-the missing link of adipo-vascular axis. J Biol Chem 2002, 277:37487-37491.
4. Yamauchi T., Kamon J., Waki H., Imai Y., Shimozawa N., Hioki K., et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 2003, 278:2461-2468.
5. Kadowaki T., Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005, 26:439-451.
6. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8:1288-1295.
7. Shetty S., Kusminski C.M., Scherer P.E. Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol Sci 2009, 30:234-239.
8. Tsao T.S., Tomas E., Murrey H.E., Hug C., Lee D.H., Ruderman N.B., et al. Role of disulfide bonds in Acrp30/Adiponectin structure and signaling specificity - different oligomers activate different signal transduction pathways. J Biol Chem 2003, 278:50810-50817.
9. Hada Y., Yamauchi T., Waki H., Tsuchida A., Hara K., Yago H., et al. Selective purification and characterization of adiponectin multimer species from human plasma. Biochem Biophys Res Commun 2007, 356:487-493.
10. Wang Y., Lam K., Yau M., Xu A. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J 2008, 409:623-633.
11. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946.
12. Kobayashi H., Ouchi N., Kihara S., Walsh K., Kumada M., Abe Y., et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004, 94:e27-e31.
13. Liang K.W., Lee W.J., Lee W.L., Ting C.T., Sheu W.H.H. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis. Clin Chim Acta 2009, 405:114-118.
14. Basu R., Pajvani U.B., Rizza R.A., Scherer P.E. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes. Diabetes 2007, 56:2174-2177.
15. Pajvani U.B., Hawkins M., Combs T.P., Rajala M.W., Doebber T., Berger J.P., et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004, 279:12152-12162.
16. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006, 116:1784-1792.
17. Koenen T.B., van Tits L.J.H., Holewijn S., Lemmers H.L.M., den Heijer M., Stalenhoef A.F.H., et al. Adiponectin multimer distribution in patients with familial combined hyperlipidemia. Biochem Biophys Res Commun 2008, 376:164-168.
18. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79-83.
19. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762-769.
20. Heiker J.T., Kosel D., Beck-Sickinger A.G. Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors. Biol Chem 2010, 391:1005-1018.
21. Siersbaek R., Nielsen R., Mandrup S. PPAR [gamma] in adipocyte differentiation and metabolism - novel insights from genome-wide studies. FEBS Lett 2010, 584:3242-3249.
22. Dagon Y., Avraham Y., Berry E.M. AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2 [alpha] in adipocytes. Biochem Biophys Res Commun 2006, 340:43-47.
23. Lee Y.S., Kim W.S., Kim K.H., Yoon M.J., Cho H.J., Shen Y., et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006, 55:2256-2264.
24. Li Y., Wang P., Zhuang Y., Lin H., Liu L., Meng Q., et al. Activation of AMPK by berberine promotes adiponectin multimerization in 3T3-L1 adipocytes. FEBS Lett 2011, 585:1735-1740.
25. Bauche I.B., Ait El Mkadem S., Rezsohazy R., Funahashi T., Maeda N., Miranda L.M., et al. Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice. Biochem Biophys Res Commun 2006, 345:1414-1424.
26. Pajvani U.B., Du X., Combs T.P., Berg A.H., Rajala M.W., Schulthess T., et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. J Biol Chem 2003, 278:9073-9085.
27. Waki H., Yamauchi T., Kamon J., Ito Y., Uchida S., Kita S., et al. Impaired multimerization of human adiponectin mutants associated with diabetes. J Biol Chem 2003, 278:40352-40363.
28. Nakano Y., Tajima S., Yoshimi A., Akiyama H., Tsushima M., Tanioka T., et al. A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. J Lipid Res 2006, 47:1572-1582.
29. Ueda H. Open sandwich immunoassay: a novel immunoassay approach based on the interchain interaction of an antibody variable region. J Biosci Bioeng 2002, 94:614-619.
30. Ueda H., Kubota K., Wang Y., Tsumoto K., Mahoney W., Kumagai I., et al. Homogeneous noncompetitive immunoassay based on the energy transfer between fluoro-labeled antibody variable domains (open sandwich fluoroimmunoassay). Biotechniques 1999, 27:738-742.
31. Iwai H., Oztürk B., Ihara M., Ueda H. Antibody affinity maturation in vitro using unconjugated peptide antigen. Ptotein Eng Des Sel 2010, 23:185-193.
32. Iwasaki R., Kiuchi H., Ihara M., Mori T., Kawakami M., Ueda H. Trans-splicing as a novel method to rapidly produce antibody fusion proteins. Biochem Biophys Res Commun 2009, 384:316-321.
33. Erickson M.G., Moon D.L., Yue D.T. DsRed as a potential FRET partner with CFP and GFP. Biophys J 2003, 85:599-611.
34. Mizuno H., Sawano A., Eli P., Hama H., Miyawaki A. Red fluorescent protein from Discosoma as a fusion tag and a partner for fluorescence resonance energy transfer. Biochemistry 2001, 40:2502-2510.
35. Ueda H. Sensitive noncompetitive measurement of small molecules by open sandwich immunoassay. Yakugaku Zasshi 2007, 38:71-80.
36. Lago F., Dieguez C., Gómez-Reino J., Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 2007, 3:716-724.
37. Rajala M.W., Scherer P.E. The adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003, 144:3765-3773.
38. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006, 55:1537-1545.
39. Tsao T.S., Murrey H.E., Hug C., Lee D.H., Lodish H.F. Oligomerization state-dependent activation of NF-κB signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem 2002, 277:29359-29362.
40. Ding Q., Wang Z., Chen Y. Endocytosis of adiponectin receptor 1 through a clathrin-and Rab5-dependent pathway. Cell Res 2008, 19:317-327.
41. Liu M., Liu F. Transcriptional and post-translational regulation of adiponectin. Biochem J 2010, 425:41-52.
42. Okuno A., Tamemoto H., Tobe K., Ueki K., Mori Y., Iwamoto K., et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998, 101:1354-1361.
43. Kubota N., Terauchi Y., Miki H., Tamemoto H., Yamauchi T., Komeda K., et al. PPAR [gamma] mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999, 4:597-609.
44. Yamauchi T., Kamon J., Waki H., Murakami K., Motojima K., Komeda K., et al. The mechanisms by which both heterozygous PPARgamma deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem 2001, 276:41245-41254.
45. West D.B., Prinz W.A., Francendese A.A., Greenwood M.R. Adipocyte blood flow is decreased in obese Zucker rats. Am J Physiol 1987, 253:R228-R233.
46. Hara K., Horikoshi M., Yamauchi T., Yago H., Miyazaki O., Ebinuma H., et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006, 29:1357-1362.